Pharmaceutical stocks bounce back

PHARMACEUTICALS

clock

The pharmaceuticals sector enjoyed a golden decade in the 1990s when a slew of innovative drugs came to the market, leading to companies generating tens of billions of dollars in profits.

However, the following 10 years have been dominated by concerns over patent expirations and increased competition from generic pharmaceuticals companies. The situation has been exacerbated by diminishing returns on research and development (R&D) investment coupled with a tougher regulatory environment. During these challenging times, many of the major pharmaceuticals companies have increasingly turned to merger and acquisition as a coping mechanism, hoping economies of scale would lead to efficiencies in both sales and R&D productivity. This has led to companies developing leaner sale...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment

Partner Insight: What You Should Know About Quant Investing

Partner Insight: What You Should Know About Quant Investing

Federated Hermes
clock 07 July 2025 • 4 min read
7IM's Ben Kumar: When behavioural biases are not all they seem

7IM's Ben Kumar: When behavioural biases are not all they seem

Investment identity more important

Ben Kumar
clock 02 July 2025 • 3 min read
Aegon AM launches UK-domiciled global income fund

Aegon AM launches UK-domiciled global income fund

In response to client demand

clock 27 June 2025 • 1 min read
Trustpilot